DOC

$17.65

Post-MarketAs of Mar 17, 8:00 PM UTC

Healthpeak Properties, Inc.

Recent News

Zacks
Mar 17, 2026

Healthpeak & Janus Living Announce Launch of Janus Living IPO

DOC launches Janus Living IPO of 37M shares at $18-$20, retaining ~85% stake post-IPO offering in its senior housing REIT spinoff.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Mar 17, 2026

Passive Income Investors Love These 5 Quality High-Yield Dividend Stocks Under $20

Most dividend investors seek solid passive income streams from quality dividend stocks. Passive income is a steady stream of unearned income that doesn’t require active traditional work. Shared ideas for earning passive income include investments such as dividend stocks, bonds, and mutual funds, as well as real estate and additional income-producing side hustles. The more ... Passive Income Investors Love These 5 Quality High-Yield Dividend Stocks Under $20

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 14, 2026

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

All have yields of at least 7% on their most recent distributions.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 12, 2026

Welltower (WELL) Down 1.2% Since Last Earnings Report: Can It Rebound?

Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Simply Wall St.
Mar 9, 2026

Healthpeak Properties (DOC) Valuation Check After Mixed Short And Long Term Shareholder Returns

Healthpeak Properties (DOC) has drawn investor attention after recent trading left the stock with mixed return figures, including a modest gain over the past 3 months but a decline over the past year. See our latest analysis for Healthpeak Properties. Recent trading paints a mixed picture for Healthpeak Properties, with a 30-day share price return of 2.55% and a 90-day share price return of 3.23%, but a 1-year total shareholder return decline of 10.21% and a 5-year total shareholder return...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.